Update on HSA's Consideration of COVID-19 Vaccines for Children and Progress of Obtaining Approval

Debated in Parliament on 2 Nov 2021.

Summary written by AI (learn more)

Assoc Prof Jamus Jerome Lim asked the Ministry of Health for an update on vaccines under consideration by the Health Sciences Authority (HSA) for children below 12 and the progress of obtaining approval.
Ong Ye Kung stated he had addressed the query in a prior reply to Question No. 72 on 1 November 2021, referring to an official report on assessment criteria for Sinovac and Sinopharm vaccines.
The response directs attention to the Official Report, Vol 95, Issue 41, for detailed information on vaccine inclusion in the National Vaccination Programme.

Questions identified by AI (learn more)

Full Transcript

Assoc Prof Jamus Jerome Lim

Assoc Prof Jamus Jerome Lim asked the Minister for Health regarding COVID-19 vaccination of children below 12 years of age, whether the Ministry can provide an update on (i) the vaccines that are currently under study or consideration by HSA and (ii) the progress of obtaining approval for use of these vaccines.

Ong Ye Kung

I thank the Member for his question. I have addressed it in my reply to Question No. 72 for oral answer on the Order Paper for 1 November 2021. [Please refer to "Assessment Criteria for Sinovac and Sinopharm COVID-19 Vaccines for Inclusion in National Vaccination Programme", Official Report, 1 November 2021, Vol 95, Issue 41, Written Answers to Questions for Oral Answer Not Answered by End of Question Time section.]

Summary written by AI (learn more)

Assoc Prof Jamus Jerome Lim asked the Ministry of Health for an update on vaccines under consideration by the Health Sciences Authority (HSA) for children below 12 and the progress of obtaining approval.
Ong Ye Kung stated he had addressed the query in a prior reply to Question No. 72 on 1 November 2021, referring to an official report on assessment criteria for Sinovac and Sinopharm vaccines.
The response directs attention to the Official Report, Vol 95, Issue 41, for detailed information on vaccine inclusion in the National Vaccination Programme.

Questions identified by AI (learn more)

Update on HSA's Consideration of COVID-19 Vaccines for Children and Progress of Obtaining Approval | PAPERCUTS

Update on HSA's Consideration of COVID-19 Vaccines for Children and Progress of Obtaining Approval

Debated in Parliament on 2 Nov 2021.

Summary written by AI (learn more)

Assoc Prof Jamus Jerome Lim asked the Ministry of Health for an update on vaccines under consideration by the Health Sciences Authority (HSA) for children below 12 and the progress of obtaining approval.
Ong Ye Kung stated he had addressed the query in a prior reply to Question No. 72 on 1 November 2021, referring to an official report on assessment criteria for Sinovac and Sinopharm vaccines.
The response directs attention to the Official Report, Vol 95, Issue 41, for detailed information on vaccine inclusion in the National Vaccination Programme.

Questions identified by AI (learn more)

Full Transcript

Assoc Prof Jamus Jerome Lim

Ong Ye Kung

Summary written by AI (learn more)

Assoc Prof Jamus Jerome Lim asked the Ministry of Health for an update on vaccines under consideration by the Health Sciences Authority (HSA) for children below 12 and the progress of obtaining approval.
Ong Ye Kung stated he had addressed the query in a prior reply to Question No. 72 on 1 November 2021, referring to an official report on assessment criteria for Sinovac and Sinopharm vaccines.
The response directs attention to the Official Report, Vol 95, Issue 41, for detailed information on vaccine inclusion in the National Vaccination Programme.

Questions identified by AI (learn more)

Update on HSA's Consideration of COVID-19 Vaccines for Children and Progress of Obtaining Approval

Summary

Questions Identified

Full Transcript

Assoc Prof Jamus Jerome Lim

Ong Ye Kung

Summary

Questions Identified

Update on HSA's Consideration of COVID-19 Vaccines for Children and Progress of Obtaining Approval

Summary

Questions Identified

Full Transcript

Assoc Prof Jamus Jerome Lim

Ong Ye Kung

Summary

Questions Identified